• Ntracts StayAlert!
  • Home
  • Login

FDA Update

Published: 11/09/2026

Sources:
  • Food and Drug Administration
Relevant To:
  • Ambulatory Surgical Centers,
  • Rural Emergency Hospitals,
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Office-Based Surgery

FDA: Vancomycin Hydrochloride for Injection USP 1.25 g/Vial-30 mL (Single Dose Vial) by Eugia US LLC (f/k/a Auro Medics Pharma LLC): Recall Due to Presence of Particulate Matter

…

Sign Up for Free Trial
  • Back
  • Ntracts Blog